SEC Form 4/A · accession 0001209191-17-033369
Adamas Pharmaceuticals Inc · ADMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jennifer J Rhodes
Officer — CBO, GC & Compliance Officer
Period of report
Jan 18, 2017
Accepted (ET)
May 17, 2017 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 28,237 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This amendment to form 4 is being filed to correct the number of shares reported in column 5 to include 1,050 shares purchased by the reporting person through the issuer's employee stock purchase plan on 11/30/16.